Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

269 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C.
Di Maio VC, Barbaliscia S, Teti E, Fiorentino G, Milana M, Paolucci S, Pollicino T, Morsica G, Starace M, Bruzzone B, Gennari W, Micheli V, Yu La Rosa K, Foroghi L, Calvaruso V, Lenci I, Polilli E, Babudieri S, Aghemo A, Raimondo G, Sarmati L, Coppola N, Pasquazzi C, Baldanti F, Parruti G, Perno CF, Angelico M, Craxì A, Andreoni M, Ceccherini-Silberstein F; HCV Virology Italian Resistance Network Group (Vironet C). Di Maio VC, et al. Among authors: sarmati l. Liver Int. 2021 Aug;41(8):1802-1814. doi: 10.1111/liv.14797. Epub 2021 Feb 8. Liver Int. 2021. PMID: 33497016
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients.
Parisi SG, Sarmati L, Pappagallo M, Mazzi R, Carolo G, Farchi F, Nicastri E, Concia E, Rezza G, Andreoni M. Parisi SG, et al. Among authors: sarmati l. J Acquir Immune Defic Syndr. 2002 Mar 1;29(3):295-9. doi: 10.1097/00126334-200203010-00011. J Acquir Immune Defic Syndr. 2002. PMID: 11873080
Stavudine protective function and emergence of Lamivudine resistance.
Nicastri E, Sarmati L, Andreoni M. Nicastri E, et al. Among authors: sarmati l. Antimicrob Agents Chemother. 2003 Mar;47(3):1176; author reply 1176. doi: 10.1128/AAC.47.3.1176.2003. Antimicrob Agents Chemother. 2003. PMID: 12604569 Free PMC article. No abstract available.
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing.
Sarmati L, Nicastri E, Uccella I, D'Ettorre G, Parisi SG, Palmisano L, Galluzzo C, Concia E, Vullo V, Vella S, Andreoni M. Sarmati L, et al. J Clin Microbiol. 2003 Apr;41(4):1760-2. doi: 10.1128/JCM.41.4.1760-1762.2003. J Clin Microbiol. 2003. PMID: 12682180 Free PMC article.
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis.
Nicastri E, Sarmati L, d'Ettorre G, Parisi SG, Palmisano L, Galluzzo C, Montano M, Uccella I, Amici R, Gatti F, Vullo V, Concia E, Vella S, Andreoni M. Nicastri E, et al. Among authors: sarmati l. J Clin Microbiol. 2003 Jul;41(7):3007-12. doi: 10.1128/JCM.41.7.3007-3012.2003. J Clin Microbiol. 2003. PMID: 12843034 Free PMC article. Clinical Trial.
Human immunodeficiency virus polymorphisms and zidovudine resistance.
Nicastri E, Sarmati L, Andreoni M, Parisi SG. Nicastri E, et al. Among authors: sarmati l. Antimicrob Agents Chemother. 2003 Aug;47(8):2714; author reply 2714-5. doi: 10.1128/AAC.47.8.2714-2715.2003. Antimicrob Agents Chemother. 2003. PMID: 12878551 Free PMC article. No abstract available.
269 results